[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06456320":3,"trial-entities:NCT06456320":83,"trial-summary:NCT06456320":89},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":20,"study_type":21,"primary_purpose":16,"phases":22,"enrollment_info":23,"interventions":26,"primary_outcomes":27,"secondary_outcomes":32,"sex":33,"minimum_age":34,"maximum_age":16,"healthy_volunteers":16,"eligibility_criteria":35,"std_ages":47,"locations":50,"central_contacts":76,"overall_officials":77,"references":81,"see_also_links":82},"NCT06456320","23-004120","Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery","ENROLLING_BY_INVITATION","2027-12-31","2025-09","2025-10-16","2024-09-05","Mayo Clinic","OTHER",false,"The purpose of this study is to use multi-omics testing on samples collected from Mayo Clinic patients to build and expand on what has been learned about genomic data.",null,[18,19],"Genetic Predisposition","Exposure, Environmental",[],"OBSERVATIONAL",[],{"count":24,"type":25},10000,"ESTIMATED",[],[28],{"measure":29,"description":30,"timeFrame":31},"Creation of a unique integrated asset of multi-omics data","A variety of patient cohorts will be ascertained throughout this study. Data will be made available to researchers to query correlations of disease states and clinical outcomes to multi-omics findings. These insights will be invaluable to creating omics-informed care plans in the future. Standard descriptive statistics approaches will be used for analysis.","Up to 5 years",[],"ALL","18 Years",{"inclusion":36,"exclusion":42,"raw_text":46},[37,38,39,40,41],"Age ≥ 18 years","Registered Mayo Clinic patient","Able to provide informed written consent","Able to receive mail and packages within a United States (US) state","Able to collect and ship samples within a US state",[43,44,45],"Active hematological cancer or history of a hematological cancer","Allogeneic Bone Marrow Transplant (e.g., samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)","Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Registered Mayo Clinic patient\n* Able to provide informed written consent\n* Able to receive mail and packages within a United States (US) state\n* Able to collect and ship samples within a US state\n\nExclusion Criteria:\n\n* Active hematological cancer or history of a hematological cancer\n* Allogeneic Bone Marrow Transplant (e.g., samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)\n* Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)",[48,49],"ADULT","OLDER_ADULT",[51,60,68],{"facility":52,"city":53,"state":54,"zip":55,"country":56,"geoPoint":57},"Mayo Clinic in Arizona","Scottsdale","Arizona","85259","United States",{"lat":58,"lon":59},33.50921,-111.89903,{"facility":61,"city":62,"state":63,"zip":64,"country":56,"geoPoint":65},"Mayo Clinic in Florida","Jacksonville","Florida","32224",{"lat":66,"lon":67},30.33218,-81.65565,{"facility":69,"city":70,"state":71,"zip":72,"country":56,"geoPoint":73},"Mayo Clinic in Rochester","Rochester","Minnesota","55905",{"lat":74,"lon":75},44.02163,-92.4699,[],[78],{"name":79,"affiliation":12,"role":80},"Konstantinos N. Lazaridis, M.D.","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":84,"biomarkers":88},[85,86,87],"Environmental","Exposure","Genetic Predisposition to Disease",[],{"nct_id":4,"found":14,"summary":16,"prompt_version":16}]